Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.961 |
51 |
|
1994 |
2018 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
1.000 |
25 |
|
1993 |
2019 |
Metastatic melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
504
|
42
|
0.100 |
None |
1.000 |
19 |
|
1994 |
2018 |
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
302
|
92
|
0.100 |
None |
1.000 |
19 |
|
1994 |
2019 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.100 |
None |
1.000 |
15 |
|
1993 |
2018 |
Dermatologic disorders
|
group |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
617
|
21
|
0.100 |
None |
1.000 |
15 |
|
2017 |
2020 |
Microphthalmos
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Congenital Abnormality
|
337
|
40
|
0.100 |
None |
1.000 |
13 |
|
1995 |
2020 |
Sentinel node (disorder)
|
disease |
|
Disease or Syndrome
|
130
|
5
|
0.100 |
None |
1.000 |
13 |
|
1999 |
2008 |
Simple buphthalmos
|
disease |
|
Congenital Abnormality
|
3
|
|
0.200 |
None |
1.000 |
11 |
|
1981 |
2011 |
ALBINOIDISM, OCULOCUTANEOUS, AUTOSOMAL DOMINANT
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Eye Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
54
|
6
|
0.090 |
None |
1.000 |
9 |
|
1987 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.080 |
None |
1.000 |
8 |
|
1987 |
2019 |
Parkinson Disease
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
2078
|
990
|
0.080 |
None |
1.000 |
8 |
|
2005 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.070 |
None |
1.000 |
7 |
|
1987 |
2019 |
Melanoma, Amelanotic
|
disease |
Neoplasms
|
Neoplastic Process
|
19
|
2
|
0.070 |
None |
1.000 |
7 |
|
1993 |
2012 |
Enzyme inhibition disorder
|
phenotype |
|
Disease or Syndrome
|
171
|
1
|
0.060 |
None |
1.000 |
6 |
|
2018 |
2019 |
Melanoma, B16
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
157
|
1
|
0.050 |
None |
1.000 |
5 |
|
1988 |
2018 |
Pigmentation Disorders
|
group |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
16
|
|
0.050 |
None |
1.000 |
5 |
|
2017 |
2019 |
Uveal melanoma
|
disease |
Neoplasms; Eye Diseases
|
Neoplastic Process
|
376
|
22
|
0.050 |
None |
1.000 |
5 |
|
1993 |
2010 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.050 |
None |
1.000 |
5 |
|
1996 |
2014 |
Amelanotic Skin Melanoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
13
|
|
0.050 |
None |
1.000 |
5 |
|
1993 |
2012 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.040 |
None |
1.000 |
4 |
|
1995 |
2019 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.340 |
None |
1.000 |
4 |
|
1991 |
2001 |
Chloasma
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
25
|
|
0.040 |
None |
1.000 |
4 |
|
2017 |
2019 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.030 |
None |
1.000 |
3 |
|
2001 |
2019 |
Neurodegenerative Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
1515
|
85
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2019 |